AI Bias Analysis
4 models · Takes ~15 seconds
Marty Makary, who resigned under pressure from the FDA, brought to the job a fundamental lack of understanding of the nature of the role, STAT's Matthew Herper writes.
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- The Labor Department's proposed rule to make it easier for employers to offer a fertility benefit isn't likely to result in many more employers doing so, although it may tip the scales for employers who were already considering...
(MedPage Today) -- Use of GLP-1 receptor agonists in breast cancer patients was linked to lower mortality and recurrence risk in a retrospective study, but experts are questioning the quality of the underlying data. At 10 years, the risk of all...
(MedPage Today) -- Two anticoagulants showed similar safety and efficacy in peritoneal dialysis (PD) patients with newly diagnosed nonvalvular atrial fibrillation (Afib), according to a retrospective study of real-world data. Among 660 patients...
(MedPage Today) -- Despite improvements in survival, the incidence of stage IV breast cancer increased significantly from 2010 through 2021, according to a U.S. population-based cohort study. The age-adjusted incidence rate of de novo stage IV...
